These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28322831)

  • 1. Chemical inhibitors of c-Met receptor tyrosine kinase stimulate osteoblast differentiation and bone regeneration.
    Kim JW; Lee MN; Jeong BC; Oh SH; Kook MS; Koh JT
    Eur J Pharmacol; 2017 Jul; 806():10-17. PubMed ID: 28322831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
    Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfuretin promotes osteoblastic differentiation in primary cultured osteoblasts and in vivo bone healing.
    Auh QS; Park KR; Yun HM; Lim HC; Kim GH; Lee DS; Kim YC; Oh H; Kim EC
    Oncotarget; 2016 Nov; 7(48):78320-78330. PubMed ID: 27713171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling.
    Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P
    J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor-induced BMP-2 expression is mediated by c-Met receptor, FAK, JNK, Runx2, and p300 pathways in human osteoblasts.
    Tsai SY; Huang YL; Yang WH; Tang CH
    Int Immunopharmacol; 2012 Jun; 13(2):156-62. PubMed ID: 22504529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking c-Met signaling enhances bone morphogenetic protein-2-induced osteoblast differentiation.
    Shibasaki S; Kitano S; Karasaki M; Tsunemi S; Sano H; Iwasaki T
    FEBS Open Bio; 2015; 5():341-7. PubMed ID: 25941631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxin augments BMP-2-induced osteoblast differentiation and bone formation.
    Moon JS; Kim SH; Oh SH; Jeong YW; Kang JH; Park JC; Son HJ; Bae S; Park BI; Kim MS; Koh JT; Ko HM
    J Bone Miner Res; 2014 Jul; 29(7):1586-96. PubMed ID: 24643989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function and mechanism of mesoporous bioactive glass adsorbed epidermal growth factor for accelerating bone tissue regeneration.
    Wang X; Chen W; Liu Q; Gao K; Wang G; Gao L; Liu L
    Biomed Mater; 2017 Apr; 12(2):025020. PubMed ID: 28452332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling.
    Li J; Hao L; Wu J; Zhang J; Su J
    Int J Mol Med; 2016 Apr; 37(4):901-10. PubMed ID: 26935542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation.
    Matsuguchi T; Chiba N; Bandow K; Kakimoto K; Masuda A; Ohnishi T
    J Bone Miner Res; 2009 Mar; 24(3):398-410. PubMed ID: 19016586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor 1 regulates ERK and GSK-3β-dependent glucocorticoid inhibition of osteoblast differentiation in murine MC3T3-E1 cells.
    Wu RW; Lin TP; Ko JY; Yeh DW; Chen MW; Ke HC; Wu SL; Wang FS
    Bone; 2011 Dec; 49(6):1255-63. PubMed ID: 21914493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo.
    Buchanan SG; Hendle J; Lee PS; Smith CR; Bounaud PY; Jessen KA; Tang CM; Huser NH; Felce JD; Froning KJ; Peterman MC; Aubol BE; Gessert SF; Sauder JM; Schwinn KD; Russell M; Rooney IA; Adams J; Leon BC; Do TH; Blaney JM; Sprengeler PA; Thompson DA; Smyth L; Pelletier LA; Atwell S; Holme K; Wasserman SR; Emtage S; Burley SK; Reich SH
    Mol Cancer Ther; 2009 Dec; 8(12):3181-90. PubMed ID: 19934279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acerogenin A, a natural compound isolated from Acer nikoense Maxim, stimulates osteoblast differentiation through bone morphogenetic protein action.
    Kihara T; Ichikawa S; Yonezawa T; Lee JW; Akihisa T; Woo JT; Michi Y; Amagasa T; Yamaguchi A
    Biochem Biophys Res Commun; 2011 Mar; 406(2):211-7. PubMed ID: 21303661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A C-Met chemical inhibitor promotes fracture healing through interacting with osteogenic differentiation via the mTORC1 pathway.
    Wang R; Xu X; Li Y; Li J; Yao C; Wu R; Jiang Q; Shi D
    Exp Cell Res; 2019 Aug; 381(1):50-56. PubMed ID: 31034806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner.
    Zhao J; Ohba S; Shinkai M; Chung UI; Nagamune T
    Biochem Biophys Res Commun; 2008 May; 369(2):444-8. PubMed ID: 18295595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
    Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
    Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.
    Okamura H; Yoshida K; Ochiai K; Haneji T
    Bone; 2011 Sep; 49(3):368-75. PubMed ID: 21683816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.